KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Other Non Operating Income: 2009-2024

Historic Other Non Operating Income for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to -$49,000.

  • Arbutus Biopharma's Other Non Operating Income fell 340.00% to -$12,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$20,000, marking a year-over-year decrease of 900.00%. This contributed to the annual value of -$49,000 for FY2024, which is 296.00% down from last year.
  • Per Arbutus Biopharma's latest filing, its Other Non Operating Income stood at -$49,000 for FY2024, which was down 296.00% from $25,000 recorded in FY2023.
  • In the past 5 years, Arbutus Biopharma's Other Non Operating Income ranged from a high of $25,000 in FY2023 and a low of -$124,000 during FY2020.
  • In the last 3 years, Arbutus Biopharma's Other Non Operating Income had a median value of -$22,000 in 2022 and averaged -$15,333.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first slumped by 540.00% in 2022, then spiked by 213.64% in 2023.
  • Arbutus Biopharma's Other Non Operating Income (Yearly) stood at -$124,000 in 2020, then surged by 104.03% to $5,000 in 2021, then slumped by 540.00% to -$22,000 in 2022, then soared by 213.64% to $25,000 in 2023, then crashed by 296.00% to -$49,000 in 2024.